KTI-2338

N/A

Report date: 2025/05/13 14:41:06
NME

Base Information

Drug NameKTI-2338
Drug Alias NameKTI-2338
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitorsHepcidin modulators
TargetsActivin receptor type-1Hepcidin
Therapy Area/IndicationsAnemia, Iron-DeficiencyAnemiaMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General HospitalNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesKeros Therapeutics IncNational Center For Advancing Translational SciencesMassachusetts General Hospital
Inactive CompaniesN/A
Active IndicationsAnemia, Iron-DeficiencyAnemiaMyositis Ossificans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A